These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22609697)

  • 1. The use of recombinant activated factor VII (rFVIIa) in the management of patients with major haemorrhage in military hospitals over the last 5 years.
    Smith JE
    Emerg Med J; 2013 Apr; 30(4):316-9. PubMed ID: 22609697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of recombinant activated factor VII on mortality in combat-related casualties with severe trauma and massive transfusion.
    Spinella PC; Perkins JG; McLaughlin DF; Niles SE; Grathwohl KW; Beekley AC; Salinas J; Mehta S; Wade CE; Holcomb JB
    J Trauma; 2008 Feb; 64(2):286-93; discussion 293-4. PubMed ID: 18301188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant activated coagulation factor VII and bleeding trauma patients.
    Rizoli SB; Nascimento B; Osman F; Netto FS; Kiss A; Callum J; Brenneman FD; Tremblay L; Tien HC
    J Trauma; 2006 Dec; 61(6):1419-25. PubMed ID: 17159685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of recombinant factor VIIa as an adjunctive therapy in damage control for wartime vascular injuries: a case control study.
    Fox CJ; Mehta SG; Cox ED; Kragh JF; Salinas J; Holcomb JB
    J Trauma; 2009 Apr; 66(4 Suppl):S112-9. PubMed ID: 19359954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry.
    Phillips LE; McLintock C; Pollock W; Gatt S; Popham P; Jankelowitz G; Ogle R; Cameron PA;
    Anesth Analg; 2009 Dec; 109(6):1908-15. PubMed ID: 19923520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of recombinant factor VIIa in US military casualties for a five-year period.
    Wade CE; Eastridge BJ; Jones JA; West SA; Spinella PC; Perkins JG; Dubick MA; Blackbourne LH; Holcomb JB
    J Trauma; 2010 Aug; 69(2):353-9. PubMed ID: 20699744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of recombinant factor VIIA for control of combat-related haemorrhage.
    Woodruff SI; Dougherty AL; Dye JL; Mohrle CR; Galarneau MR
    Emerg Med J; 2010 Feb; 27(2):121-4. PubMed ID: 20156864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current evidence based guidelines for factor VIIa use in trauma: the good, the bad, and the ugly.
    Duchesne JC; Mathew KA; Marr AB; Pinsky MR; Barbeau JM; McSwain NE
    Am Surg; 2008 Dec; 74(12):1159-65. PubMed ID: 19097529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UK defence medical services guidance for the use of recombinant factor VIIa (rFVIIa) in the deployed military setting.
    Hodgetts TJ; Kirkman E; Mahoney PF; Russell R; Thomas R; Midwinter M
    J R Army Med Corps; 2007 Dec; 153(4):307-9. PubMed ID: 18619169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applicability and safety of recombinant activated factor VII to control non-haemophilic haemorrhage: investigational experience in 265 children.
    Herbertson M; Kenet G
    Haemophilia; 2008 Jul; 14(4):753-62. PubMed ID: 18445016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early versus late recombinant factor VIIa in combat trauma patients requiring massive transfusion.
    Perkins JG; Schreiber MA; Wade CE; Holcomb JB
    J Trauma; 2007 May; 62(5):1095-9; discussion 1099-101. PubMed ID: 17495707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Off-label use of recombinant factor VII (rFVIIa) in teaching hospitals in Paris in 2010].
    Bardon J; Fink J; de Montblanc J; Bergmann JF; Sarrut B; Benhamou D
    Ann Fr Anesth Reanim; 2013 Oct; 32(10):659-64. PubMed ID: 23953834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery.
    Bishop CV; Renwick WE; Hogan C; Haeusler M; Tuckfield A; Tatoulis J
    Ann Thorac Surg; 2006 Mar; 81(3):875-9. PubMed ID: 16488687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Activated Factor VII in Patients with Diffuse Alveolar Hemorrhage: A 10 Years Institutional Experience.
    Pathak V; Kuhn J; Gabriel D; Barrow J; Jennette JC; Henke DC
    Lung; 2015 Jun; 193(3):375-9. PubMed ID: 25802198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of recombinant factor VIIa in warfarin patients with traumatic brain injury: a retrospective case-control study.
    DeLoughery EP; Lenfesty B; DeLoughery TG
    Blood Coagul Fibrinolysis; 2013 Apr; 24(3):317-20. PubMed ID: 23429251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Off-label use of recombinant factor VIIa in two tertiary hospitals in Queensland.
    Donovan PJ; Iedema J; McLeod DS; Kubler P; Pillans P
    ANZ J Surg; 2013 Mar; 83(3):149-54. PubMed ID: 23137066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of recombinant-activated factor VII in bleeding trauma patients.
    Dutton RP; Conti BM
    Curr Opin Anaesthesiol; 2009 Apr; 22(2):299-304. PubMed ID: 19295430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications of recombinant activated human coagulation factor VII.
    Howes JL; Smith RS; Helmer SD; Taylor SM
    Am J Surg; 2009 Dec; 198(6):895-9. PubMed ID: 19969148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant activated factor VII increases survival time in a model of incompressible arterial hemorrhage in the anesthetized pig.
    Sapsford W; Watts S; Cooper G; Kirkman E
    J Trauma; 2007 Apr; 62(4):868-79. PubMed ID: 17426541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant factor VIIa as last-resort treatment of desperate haemorrhage.
    Palmason R; Vidarsson B; Sigvaldason K; Ingimarsson JP; Gudbjartsson T; Sigurdsson GH; Onundarson PT
    Acta Anaesthesiol Scand; 2012 May; 56(5):636-44. PubMed ID: 22489992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.